patient
|
14 |
Age
|
62 |
Gender
|
male |
Origin
|
Germany |
Genotype
|
A |
PC_CP mutation
|
rtV173L, rtL180M, rtM204V |
Weight(kg)
|
64 |
Duration of Pretreatment with Lamivudine (mo)
|
15 |
HBeAg Status at Baseline ADV
|
negative |
HBV DNA at Baseline ADV (log10 copies/mL)
|
6.99 |
Duration of ADV Therapy (mo)
|
18 |
HBV DNA at Baseline TDF (log10 copies/mL)
|
6.38 |